Finance

Lists
539523:BOM
Alkem Laboratories Ltd
₹5 054,60
-1,58%
(-81,00) 1D
16 Okt., 15:54:51 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 539523...
Open
₹5 135,00
High
₹5 136,60
Low
₹5 042,55
Mkt. cap
604,36 mjd
Avg. vol.
14,02 k
Volume
51,72 k
Dividend
1,05%
Quarterly dividend
₹13,25
Ex-dividend date
07 Aug. 2026
P/E ratio
28,01
52-wk high
₹5 933,00
52-wk low
₹5 042,55
EPS
₹180,45
Shares outstanding
119,55 m
No. of employees
19 k
Open
₹5 135,00
High
₹5 136,60
Low
₹5 042,55
Mkt. cap
604,36 mjd
Avg. vol.
14,02 k
Volume
51,72 k
Dividend
1,05%
Quarterly dividend
₹13,25
Ex-dividend date
07 Aug. 2026
P/E ratio
28,01
52-wk high
₹5 933,00
52-wk low
₹5 042,55
EPS
₹180,45
Shares outstanding
119,55 m
No. of employees
19 k
News stories
From web sources and news partners
Profile
Alkem Laboratories Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Specialising in generics and speciality pharmaceuticals, Alkem manufactures and markets pharmaceutical generics, formulations and nutraceuticals across India and global markets. Wikipedia
About Alkem Laboratories Ltd
CEO-
Employees19,3 k
Founded1973
HeadquartersMumbai, Maharashtra, Indië
SectorPharmaceutical industry
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
40,01 mjd
37,37 mjd
36,03 mjd
37,40 mjd
Cost of goods sold
14,01 mjd
12,73 mjd
14,33 mjd
12,01 mjd
Cost of revenue
14,01 mjd
12,73 mjd
14,33 mjd
12,01 mjd
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7,10 mjd
7,22 mjd
17,12 mjd
8,09 mjd
Operating expense
17,73 mjd
17,31 mjd
17,80 mjd
18,73 mjd
Total operating expenses
31,74 mjd
30,04 mjd
32,13 mjd
30,74 mjd
Operating income
8,27 mjd
7,33 mjd
3,90 mjd
6,66 mjd
Other non operating income
1,04 mjd
1,43 mjd
-3,55 mjd
1,53 mjd
EBT including unusual items
8,95 mjd
7,81 mjd
4,22 mjd
7,71 mjd
EBT excluding unusual items
8,95 mjd
8,33 mjd
4,77 mjd
7,71 mjd
Income tax expense
1,16 mjd
1,28 mjd
1,71 mjd
2,50 mjd
Effective tax rate
12,98%
16,35%
40,53%
32,47%
Other operating expenses
9,69 mjd
9,15 mjd
-378,70 m
9,64 mjd
Net income
7,65 mjd
6,36 mjd
2,36 mjd
5,20 mjd
Net profit margin
19,12%
17,02%
6,56%
13,90%
Earnings per share
63,99
56,88
26,50
43,49
Interest and investment income
-
-
3,92 mjd
-
Interest expense
-350,20 m
-421,00 m
-336,50 m
-466,20 m
Net interest expenses
-350,20 m
-421,00 m
3,58 mjd
-466,20 m
Depreciation and amortization charges
936,10 m
950,10 m
1,06 mjd
1,00 mjd
EBITDA
9,18 mjd
8,11 mjd
4,67 mjd
7,43 mjd
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme